These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 3160514)
41. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon. Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925 [TBL] [Abstract][Full Text] [Related]
42. Release of immune complexes bound to CR1 on erythrocytes; suramin inhibits factor I in the presence of EDTA. Thomsen BS; Nielsen H; Bendixen G Allergy; 1986 Sep; 41(7):487-92. PubMed ID: 2947512 [TBL] [Abstract][Full Text] [Related]
43. Influence of processing by erythrocyte C3b/C4b receptors (CR1) on binding of immune complexes to Raji cells and polymorphonuclear granulocytes. Rasmussen JM; Jepsen HH; Svehag SE Scand J Immunol; 1987 Oct; 26(4):437-44. PubMed ID: 2961050 [TBL] [Abstract][Full Text] [Related]
44. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967 [TBL] [Abstract][Full Text] [Related]
46. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364 [TBL] [Abstract][Full Text] [Related]
47. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum. Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998 [TBL] [Abstract][Full Text] [Related]
48. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus. Verma J; Arora V; Marwaha V; Kumar A; Das N Lupus; 2005; 14(4):273-9. PubMed ID: 15864913 [TBL] [Abstract][Full Text] [Related]
49. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes. Gibson NC; Waxman FJ Clin Immunol Immunopathol; 1994 Feb; 70(2):104-13. PubMed ID: 8299225 [TBL] [Abstract][Full Text] [Related]
50. C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus. Fyfe A; Holme ER; Zoma A; Whaley K Clin Exp Immunol; 1987 Feb; 67(2):300-8. PubMed ID: 2955969 [TBL] [Abstract][Full Text] [Related]
51. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions. Ng YC; Schifferli JA; Walport MJ Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204 [TBL] [Abstract][Full Text] [Related]
52. Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans. Paccaud JP; Steiger G; Sjöholm AG; Spaeth PJ; Schifferli JA Clin Exp Immunol; 1987 Aug; 69(2):468-76. PubMed ID: 2958199 [TBL] [Abstract][Full Text] [Related]
53. Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus. Horgan C; Taylor RP Arthritis Rheum; 1984 Mar; 27(3):320-9. PubMed ID: 6546694 [TBL] [Abstract][Full Text] [Related]
54. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study. Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768 [TBL] [Abstract][Full Text] [Related]
55. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria. Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050 [TBL] [Abstract][Full Text] [Related]
56. An enzyme based assay for the measurement of complement mediated binding of immune complexes to red blood cells. Rafnar BO; Traustadóttir KH; Sigfússon A; Arason GJ; Valdimarsson H; Erlendsson K J Immunol Methods; 1998 Feb; 211(1-2):171-81. PubMed ID: 9617841 [TBL] [Abstract][Full Text] [Related]
57. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells. Emlen W; Burdick G; Carl V; Lachmann PJ J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529 [TBL] [Abstract][Full Text] [Related]
58. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. Yoon SH; Fearon DT J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931 [TBL] [Abstract][Full Text] [Related]
59. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Hepburn AL; Mason JC; Davies KA Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618 [TBL] [Abstract][Full Text] [Related]
60. [The occurrence of defective C3b receptors (CR1) on erythrocytes in connective tissue diseases--their relation to Sjögren's syndrome and SLE]. Inokuma S; Matsumura Y; Kisaki T; Hayakawa T Ryumachi; 1986 Jun; 26(3):153-8. PubMed ID: 2947339 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]